AQR Arbitrage’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

AQR Arbitrage’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-113,518	Closed	-$4.36M	–	925
2023 Q2	$4.36M	Buy	+113,518	New	+$2.92M	0.19%	134

AQR Arbitrage's KDNY Position: Q3 2023 in Review

AQR Arbitrage sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 113,518 shares — an estimated $4.36M sold.

AQR Arbitrage first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $4.36M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

AQR Arbitrage reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
AQR Arbitrage sold 113,518 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $4.36M.
AQR Arbitrage first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
AQR Arbitrage's Chinook Therapeutics, Inc. Common Stock position peaked at $4.36M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.